Advertisement
Loading...

HCW Biologics Inc.

HCWB•NASDAQ
Healthcare
Biotechnology
$1.22
$0.88(262.02%)
U.S. Market opens in 39h 31m

HCW Biologics Inc. (HCWB) Stock Overview

Explore HCW Biologics Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.5M
P/E Ratio-4.18
EPS (TTM)$-10.63
ROE-1.02%
Fundamental Analysis

AI Price Forecasts

1 Month$0.18
3 Months$0.00
1 Year Target$2.22

HCWB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of HCW Biologics Inc. (HCWB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 82.54, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $2.22.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.18 and a market capitalization of 2.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
262.02%
5-Day Change
280.66%
1-Month Change
199.75%
3-Month Change
87.66%
6-Month Change
-59.33%
Year-to-Date (YTD) Change
25.70%
1-Year Change
-85.12%
3-Year Change
-97.93%
5-Year Change
-99.52%
All-Time (Max) Change
-99.52%

Contact Information

https://www.hcwbiologics.com
954 842 2024
2929 North Commerce Parkway, Miramar, FL, 33025

Company Facts

36 Employees
IPO DateJul 20, 2021
CountryUS
Actively Trading

Frequently Asked Questions